World's Best Scientists 2026 revealed!
Award Badge
Microbiology
South Africa
2026

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Microbiology 70 1897 1727 9 9 242 24465
Medicine 72 19773 18546 46 41 286 25564

Ian Sanne publications per year

The chart shows the history of publications by Ian Sanne between 2000 and 2025, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Ian Sanne published across 26 years, from 2000 to 2025, averaging 11.5 papers a year. Output peaked at 30 publications in 2013. 6 of the 299 publications appeared in the last two years.

No. of publications
10 20 30
Bar chart. Horizontal axis: year, 2000 to 2025. Vertical axis: number of publications, 0 to 30. Peak 30 publications in 2013. 2000: 1 publication 2001: 2 publications 2002: 2 publications 2003: 5 publications 2004: 3 publications 2005: 7 publications 2006: 5 publications 2007: 4 publications 2008: 12 publications 2009: 11 publications 2010: 21 publications 2011: 20 publications 2012: 19 publications 2013: 30 publications 2014: 22 publications 2015: 11 publications 2016: 23 publications 2017: 21 publications 2018: 10 publications 2019: 9 publications 2020: 10 publications 2021: 25 publications 2022: 15 publications 2023: 5 publications 2024: 4 publications 2025: 2 publications
2000 2025

299 publications in total across all disciplines

View publications per year as a table
Ian Sanne: publications per year, 2000 to 2025
Year Publications
2000 1
2001 2
2002 2
2003 5
2004 3
2005 7
2006 5
2007 4
2008 12
2009 11
2010 21
2011 20
2012 19
2013 30
2014 22
2015 11
2016 23
2017 21
2018 10
2019 9
2020 10
2021 25
2022 15
2023 5
2024 4
2025 2
Total 299
Download as CSV

Ian Sanne publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Ian Sanne sits on this spectrum.

No. of scientists
50 100 150 200 250
Bar chart with 64 bars. Horizontal axis: publications, 55–64 to 679+. Vertical axis: number of scientists, 0 to 288. Most scientists, 288, have 135–144 publications. The last bar groups every scientist with 679 publications or more. The highlighted bar, 235–244 publications, is where this scientist sits. 55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 265 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 234 scientists 205–214 publications: 208 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55–64 publications 679+

This scientist: 242 publications — 63rd percentile

63% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

View publications distribution as a table
Number of Microbiology scientists by publication count, Research.com 2026 ranking edition. Based on 5,513 ranked scientists.
Publications Scientists This scientist
55–64 8
65–74 29
75–84 55
85–94 112
95–104 137
105–114 190
115–124 235
125–134 234
135–144 288
145–154 265
155–164 264
165–174 253
175–184 276
185–194 190
195–204 234
205–214 208
215–224 198
225–234 155
235–244 161 242
245–254 160
255–264 146
265–274 139
275–284 148
285–294 115
295–304 96
305–314 88
315–324 106
325–334 65
335–344 76
345–354 64
355–364 62
365–374 65
375–384 61
385–394 34
395–404 44
405–414 36
415–424 35
425–434 29
435–444 33
445–454 34
455–464 25
465–474 26
475–484 20
485–494 19
495–504 16
505–514 17
515–524 23
525–534 14
535–544 14
545–554 18
555–564 12
565–574 7
575–584 9
585–594 9
595–604 9
605–614 7
615–624 9
625–634 7
635–644 4
645–654 5
655–664 6
665–674 7
675–678 3
679+ 99
Download as CSV

Ian Sanne D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Ian Sanne sits on this spectrum.

No. of scientists
50 100 150
Bar chart with 88 bars. Horizontal axis: D-Index, 40 to 127+. Vertical axis: number of scientists, 0 to 162. Most scientists, 162, have 58 D-Index. The last bar groups every scientist with 127 D-Index or more. The highlighted bar, 70 D-Index, is where this scientist sits. 40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 112 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 123 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 94 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 70 D-Index — 66th percentile

66% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

View D-Index distribution as a table
Number of Microbiology scientists by D-index, Research.com 2026 ranking edition. Based on 5,513 ranked scientists.
D-Index Scientists This scientist
40 30
41 86
42 90
43 117
44 122
45 123
46 108
47 110
48 106
49 109
50 129
51 111
52 116
53 127
54 134
55 134
56 112
57 136
58 162
59 151
60 139
61 123
62 126
63 144
64 109
65 103
66 124
67 112
68 103
69 131
70 94 70
71 93
72 96
73 92
74 80
75 66
76 87
77 60
78 73
79 59
80 57
81 55
82 47
83 77
84 50
85 45
86 42
87 41
88 32
89 38
90 35
91 34
92 27
93 26
94 33
95 22
96 37
97 22
98 21
99 22
100 30
101 16
102 20
103 17
104 19
105 16
106 19
107 18
108 14
109 10
110 9
111 7
112 11
113 6
114 15
115 10
116 12
117 7
118 10
119 10
120 11
121 2
122 7
123 12
124 5
125 9
126 6
127+ 95
Download as CSV

Research.com Recognitions

  • 2026 - Research.com Microbiology in South Africa Leader Award

Overview

Ian Sanne is affiliated with the University of the Witwatersrand in South Africa. Their research primarily focuses on the field of Medicine, with particular expertise in Infectious Diseases, Epidemiology, Virology, Health, and Emergency Medicine.

They have contributed extensively to topics such as HIV/AIDS Research and Interventions, SARS-CoV-2 and COVID-19 Research, HIV Research and Treatment, COVID-19 Clinical Research Studies, HIV/AIDS drug development and treatment, Vaccine Coverage and Hesitancy, and HIV, Drug Use, Sexual Risk.

Frequent coauthors in Ian Sanne's work include Charles Chasela, Linda-Gail Bekker, Glenda Gray, Nigel Garrett, and Ameena Goga.

Prominent venues where Ian Sanne's research has been published include UNC Libraries, bioRxiv (Cold Spring Harbor Laboratory), South African Medical Journal, Clinical Infectious Diseases, and PLoS ONE.

Significant recent papers authored or coauthored by Ian Sanne are:

  • High Asymptomatic Carriage With the Omicron Variant in South Africa, 2022, Clinical Infectious Diseases
  • Multimonth dispensing of up to 6 months of antiretroviral therapy in Malawi and Zambia (INTERVAL): a cluster-randomised, non-blinded, non-inferiority trial, 2021, The Lancet Global Health
  • Twelve-Month Outcomes of Community-Based Differentiated Models of Multimonth Dispensing of ART Among Stable HIV-Infected Adults in Lesotho: A Cluster-Randomized Noninferiority Trial, 2020, JAIDS Journal of Acquired Immune Deficiency Syndromes
  • Thromboembolic Events in the South African Ad26.COV2.S Vaccine Study, 2021, New England Journal of Medicine
  • Applying machine learning and predictive modeling to retention and viral suppression in South African HIV treatment cohorts, 2022, Scientific Reports

Best Publications

  • Prevention of HIV-1 Infection with Early Antiretroviral Therapy

    Myron S. Cohen;Ying Q. Chen;Marybeth McCauley;Theresa Gamble

  • Timing of Antiretroviral Therapy for HIV-1 Infection and Tuberculosis

    Diane V. Havlir;Michelle A. Kendall;Prudence Ive;Johnstone Kumwenda

  • Early antiretroviral therapy reduces AIDS progression/death in individuals with acute opportunistic infections: a multicenter randomized strategy trial

    Andrew R. Zolopa;Janet Andersen;Lauren Komarow;Ian Sanne

  • Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trial

    Beatriz Grinsztejn;Mina C. Hosseinipour;Heather J. Ribaudo;Susan Swindells

  • Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis.

    Susan E. Dorman;Payam Nahid;Ekaterina V. Kurbatova;Patrick P.J. Phillips

  • High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trial

    Martin J Boeree;Norbert Heinrich;Rob Aarnoutse;Andreas H Diacon

  • Initiating Antiretroviral Therapy for HIV at a Patient’s First Clinic Visit: The RapIT Randomized Controlled Trial

    Sydney Rosen;Sydney Rosen;Mhairi Maskew;Matthew P. Fox;Matthew P. Fox;Cynthia Nyoni

  • Severe hepatotoxicity associated with nevirapine use in HIV-infected subjects.

    Ian Sanne;Herve Mommeja-Marin;John Hinkle;John A. Bartlett

  • Nurse versus doctor management of HIV-infected patients receiving antiretroviral therapy (CIPRA-SA): a randomised non-inferiority trial

    Ian Sanne;Catherine Orrell;Matthew P Fox;Francesca Conradie

  • Xpert(®) MTB/RIF for point-of-care diagnosis of TB in high-HIV burden, resource-limited countries: hype or hope?

    Annelies Van Rie;Liesl Page-Shipp;Lesley Scott;Ian Sanne

  • Results of a phase 2 clinical trial at 48 weeks (AI424-007): a dose-ranging, safety, and efficacy comparative trial of atazanavir at three doses in combination with didanosine and stavudine in antiretroviral-naive subjects.

    Ian Sanne;Peter Piliero;Kathleen Squires;Alexandra Thiry

  • Whole-genome sequencing to establish relapse or re-infection with Mycobacterium tuberculosis: a retrospective observational study

    Josephine M Bryant;Simon R Harris;Julian Parkhill;Rodney Dawson

  • Opportunities and challenges for HIV care in overlapping HIV and TB epidemics.

    Diane V. Havlir;Haileyesus Getahun;Ian Sanne;Paul Nunn

  • Comparison of Xpert MTB/RIF with Other Nucleic Acid Technologies for Diagnosing Pulmonary Tuberculosis in a High HIV Prevalence Setting: A Prospective Study

    Lesley E. Scott;Kerrigan McCarthy;Natasha Gous;Matilda Nduna

  • A Multicenter Randomized Trial Evaluating Posaconazole versus Fluconazole for the Treatment of Oropharyngeal Candidiasis in Subjects with HIV/AIDS

    Jose A. Vazquez;Daniel J. Skiest;Leopoldo Nieto;Rebeca Northland

  • Dose-ranging, randomized, clinical trial of atazanavir with lamivudine and stavudine in antiretroviral-naive subjects: 48-week results.

    Robert Leo Murphy;Ian Sanne;Pedro Cahn;Praphan Phanuphak

  • SARS-CoV-2 Antigens Expressed in Plants Detect Antibody Responses in COVID-19 Patients

    Mohau S Makatsa;Marius B Tincho;Jerome M Wendoh;Sherazaan D Ismail

  • The Impact and Cost of Scaling up GeneXpert MTB/RIF in South Africa

    Gesine Meyer-Rath;Gesine Meyer-Rath;Kathryn Schnippel;Lawrence Long;William MacLeod;William MacLeod

  • Risk Factor Analyses for Immune Reconstitution Inflammatory Syndrome in a Randomized Study of Early vs. Deferred ART during an Opportunistic Infection

    Philip M. Grant;Lauren Komarow;Janet Andersen;Irini Sereti

  • Pharmacogenetics of nevirapine-associated hepatotoxicity: an Adult AIDS Clinical Trials Group collaboration.

    David W. Haas;John A. Bartlett;Janet W. Andersen;Ian Sanne

Frequent Co-Authors

Wendy S. Stevens
Wendy S. Stevens National Health Laboratory Service
Luis J. Montaner
Luis J. Montaner The Wistar Institute
Beatriz Grinsztejn
Beatriz Grinsztejn Oswaldo Cruz Foundation
Michael M. Lederman
Michael M. Lederman Case Western Reserve University
Robin Wood
Robin Wood University of Cape Town
Joseph J. Eron
Joseph J. Eron University of North Carolina at Chapel Hill
Diane V. Havlir
Diane V. Havlir University of California, San Francisco
Gavin J. Churchyard
Gavin J. Churchyard Aurum Institute
Audrey Pettifor
Audrey Pettifor University of North Carolina at Chapel Hill
Kenneth H. Mayer
Kenneth H. Mayer Harvard Medical School

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring online degrees related to Microbiology can broaden your career options and offer flexible learning opportunities. For those interested in the health sciences, consider medical degrees online that pay well, which can lead to rewarding positions in healthcare and research.

Public health is another complementary field. Many students find online mph programs easy to get into, allowing for a smoother transition into careers focusing on community health, epidemiology, or healthcare administration.

With a strong foundation in biology and psychology, becoming a child life specialist is also a viable pathway. Understanding child life specialist salary with bachelor degree information can help set realistic expectations while planning your career trajectory.

Additionally, some online colleges that accept felons offer inclusive opportunities for those with records seeking a fresh start in education. These programs emphasize accessibility and can support diverse student backgrounds as they work toward degrees in fields related to microbiology and health sciences.

Best Scientists Citing Ian Sanne

Trending Scientists

Recently Published Articles